Cybin Inc. (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative ...

CYBN) surged as much as 10% on Monday, reaching their highest level since May, following the announcement of “unprecedented” ...

(SILO), Monday announced positive results from a pre-clinical study of SPC-15 showing potential for the treatment of major depressive disorder, and other severe stress-related conditions ... severe ...

Cybin has reported 71% remission in patients with major depressive disorder (MDD) who received two doses of the ... that are ...

Dual-action approach combining 5-HT4R Agonist (SPC-15) and NMDAR antagonist demonstrates enhanced efficacy in preclinical ...

Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product ...

Most people want less anxiety. The goal is to actually have realistic anxiety levels. Here, I explain how to attain realistic ...

This new formulation, which targets both the serotonin 5-HT4 receptor (5-HT4R) and the NMDA receptor (NMDAR), has shown potential as a treatment for major depressive disorder (MDD), and other severe ...

Mental health, a topic that sends chills down the spine, is no longer a phenomenon that ‘happens to others’. According to the ...

The company's lead program, SPC-15, is an intranasal treatment targeting post-traumatic stress disorder (“PTSD”) and stress-induced anxiety disorders. SP-26 is a time-release, ketamine-loaded implant ...

My teen has tried three different online therapy services, but Fort Health was the best experience by far. Read my full ...

As the leaves conclude their falling and the temperature begins to drop, spirits tend to decline as well. Whether it’s caused ...